annual current liabilities:
$23.44M+$21.05M(+880.34%)Summary
- As of today (September 15, 2025), SPRY annual total current liabilities is $23.44 million, with the most recent change of +$21.05 million (+880.34%) on December 31, 2024.
- During the last 3 years, SPRY annual current liabilities has risen by +$15.25 million (+186.31%).
- SPRY annual current liabilities is now at all-time high.
Performance
SPRY Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$45.60M+$17.98M(+65.08%)Summary
- As of today (September 15, 2025), SPRY quarterly total current liabilities is $45.60 million, with the most recent change of +$17.98 million (+65.08%) on June 30, 2025.
- Over the past year, SPRY quarterly current liabilities has increased by +$38.87 million (+578.05%).
- SPRY quarterly current liabilities is now at all-time high.
Performance
SPRY quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SPRY Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +880.3% | +578.0% |
3 y3 years | +186.3% | +309.2% |
5 y5 years | +30.8% | - |
SPRY Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +880.3% | at high | +1807.1% |
5 y | 5-year | at high | +880.3% | at high | +1807.1% |
alltime | all time | at high | +880.3% | at high | +1807.1% |
SPRY Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $45.60M(+65.1%) |
Mar 2025 | - | $27.62M(+17.8%) |
Dec 2024 | $23.44M(+880.3%) | $23.44M(+41.0%) |
Sep 2024 | - | $16.62M(+147.2%) |
Jun 2024 | - | $6.72M(+81.0%) |
Mar 2024 | - | $3.71M(+55.4%) |
Dec 2023 | $2.39M(-56.1%) | $2.39M(-78.6%) |
Sep 2023 | - | $11.18M(+11.2%) |
Jun 2023 | - | $10.05M(+2.2%) |
Mar 2023 | - | $9.84M(+146.6%) |
Dec 2022 | $5.44M | - |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $3.99M(-64.2%) |
Jun 2022 | - | $11.14M(-24.8%) |
Mar 2022 | - | $14.81M(-0.6%) |
Dec 2021 | $8.19M(-14.7%) | - |
Dec 2021 | - | $14.89M(-3.0%) |
Sep 2021 | - | $15.35M(-1.3%) |
Jun 2021 | - | $15.55M(+34.1%) |
Mar 2021 | - | $11.60M(+20.8%) |
Dec 2020 | $9.60M(-46.4%) | $9.60M(-46.4%) |
Dec 2019 | $17.93M(+248.5%) | $17.93M |
Dec 2018 | $5.14M | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is ARS Pharmaceuticals, Inc. annual total current liabilities?
The current annual current liabilities of SPRY is $23.44M
What is the all time high annual current liabilities for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual total current liabilities is $23.44M
What is ARS Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, SPRY annual total current liabilities has changed by +$21.05M (+880.34%)
What is ARS Pharmaceuticals, Inc. quarterly total current liabilities?
The current quarterly current liabilities of SPRY is $45.60M
What is the all time high quarterly current liabilities for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly total current liabilities is $45.60M
What is ARS Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, SPRY quarterly total current liabilities has changed by +$38.87M (+578.05%)